Valproic Acid for Treatment of Hyperactive or Mixed Delirium in ICU
Sponsor: Stanford University
Terminated
We did not recruit the research assistant and terminated the study
Listed as NCT02343575, this PHASE4 trial focuses on Hyperactive Delirium and Mixed Delirium and remains terminated or withdrawn. Sponsored by Stanford University, it has been updated 11 times since 2015, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
11 versions recorded-
Sep 2024 — Present [monthly]
Terminated PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE4
-
Jan 2023 — Jul 2024 [monthly]
Terminated PHASE4
-
Dec 2022 — Jan 2023 [monthly]
Terminated PHASE4
-
Dec 2021 — Dec 2022 [monthly]
Terminated PHASE4
▶ Show 6 earlier versions
-
Jan 2021 — Dec 2021 [monthly]
Terminated PHASE4
-
Jul 2019 — Jan 2021 [monthly]
Terminated PHASE4
-
Jun 2019 — Jul 2019 [monthly]
Terminated PHASE4
Status: Suspended → Terminated
-
Jun 2018 — Jun 2019 [monthly]
Suspended PHASE4
-
Feb 2017 — Jun 2018 [monthly]
Suspended PHASE4
-
Jan 2017 — Feb 2017 [monthly]
Suspended PHASE4
First recorded
Jan 2015
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Stanford University
For direct contact, visit the study record on ClinicalTrials.gov .